Keveyis is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Strongbridge Us Inc.. The primary component is Dichlorphenamide.
| Product ID | 71090-001_035fd70c-1b8d-4e6a-b9db-79dd089107a7 |
| NDC | 71090-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Keveyis |
| Generic Name | Dichlorphenamide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-08-07 |
| Marketing Category | NDA / NDA |
| Application Number | NDA011366 |
| Labeler Name | Strongbridge US Inc. |
| Substance Name | DICHLORPHENAMIDE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [CS],Carbonic Anhydrase Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2017-02-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA011366 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-02-21 |
| Ingredient | Strength |
|---|---|
| DICHLORPHENAMIDE | 50 mg/1 |
| SPL SET ID: | 2d4d6a8e-3122-4b91-b46a-5708e60ea5c1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 51672-4177 | Keveyis | Dichlorphenamide |
| 71090-001 | Keveyis | Dichlorphenamide |
| 72065-001 | Keveyis | Dichlorphenamide |
| 51672-4144 | DARANIDE | dichlorphenamide |
| 13668-676 | Dichlorphenamide | Dichlorphenamide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() KEVEYIS 86724075 5034655 Live/Registered |
TARO PHARMACEUTICALS U.S.A., INC. 2015-08-13 |